I wanted to quickly thank Claudia Whitehead at the Phoenix Community and Economic Development for hosting me at the Phoenix Biomedical Campus, which will host many pioneers in translational genomics and molecular profiling in the future; right in the heart of Phoenix,Arizona.
The City of Phoenix healthcare and biomedical ecosystem is comprised of nearly 9,400 enterprises that supports more than 221k jobs. This 30-acre hub for clinical trial activity is already home to the world’s leading research institutions. Translational Genomics Research Institute (TGen), Critical Path Institute (C-Path), Arizona State University, University of Arizona, Northern Arizona University, Phoenix Children’s Hospital, Banner Health, Dignity Health, Creighton University School of Medicine, and will all be driving an immense amount of innovation here in the future.
The more I think about it, Phoenix is perfectly-situated to support the commercialization of wearable and mobile health technologies, with a high degree of transferable resilient infrastructure technology anticipated from local defense contractors and FFRDCs.